# Study of Treosulfan-Based Conditioning for HSCT in Nijmegen Breakage Syndrome

> **NCT07316595** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Federal Research Institute of Pediatric Hematology, Oncology and Immunology** · enrollment: 24 (estimated)

## Conditions studied

- HSCT
- Nijmegen Breakage Syndrome
- Treosulfan Based Conditioning

## Interventions

- **DRUG:** Treosulfan (Treo)

## Key facts

- **NCT ID:** NCT07316595
- **Lead sponsor:** Federal Research Institute of Pediatric Hematology, Oncology and Immunology
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-12-30
- **Primary completion:** 2028-12-31
- **Final completion:** 2030-12-31
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2026-01-05

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07316595

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07316595, "Study of Treosulfan-Based Conditioning for HSCT in Nijmegen Breakage Syndrome". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT07316595. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*